Cargando…

Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats

The aims of the present study were to analyze the effect of resveratrol on liver steatosis in obese rats, to compare the effects induced by resveratrol and energy restriction and to research potential additive effects. Rats were initially fed a high-fat high-sucrose diet for six weeks and then alloc...

Descripción completa

Detalles Bibliográficos
Autores principales: Milton-Laskibar, Iñaki, Aguirre, Leixuri, Fernández-Quintela, Alfredo, Rolo, Anabela P., Soeiro Teodoro, João, Palmeira, Carlos M., Portillo, María P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537851/
https://www.ncbi.nlm.nih.gov/pubmed/28696376
http://dx.doi.org/10.3390/nu9070737
_version_ 1783254260232749056
author Milton-Laskibar, Iñaki
Aguirre, Leixuri
Fernández-Quintela, Alfredo
Rolo, Anabela P.
Soeiro Teodoro, João
Palmeira, Carlos M.
Portillo, María P.
author_facet Milton-Laskibar, Iñaki
Aguirre, Leixuri
Fernández-Quintela, Alfredo
Rolo, Anabela P.
Soeiro Teodoro, João
Palmeira, Carlos M.
Portillo, María P.
author_sort Milton-Laskibar, Iñaki
collection PubMed
description The aims of the present study were to analyze the effect of resveratrol on liver steatosis in obese rats, to compare the effects induced by resveratrol and energy restriction and to research potential additive effects. Rats were initially fed a high-fat high-sucrose diet for six weeks and then allocated in four experimental groups fed a standard diet: a control group, a resveratrol-treated group, an energy restricted group and a group submitted to energy restriction and treated with resveratrol. We measured liver triacylglycerols, transaminases, FAS, MTP, CPT1a, CS, COX, SDH and ATP synthase activities, FATP2/FATP5, DGAT2, PPARα, SIRT1, UCP2 protein expressions, ACC and AMPK phosphorylation and PGC1α deacetylation. Resveratrol reduced triacylglycerols compared with the controls, although this reduction was lower than that induced by energy restriction. The mechanisms of action were different. Both decreased protein expression of fatty acid transporters, thus suggesting reduced fatty acid uptake from blood stream and liver triacylglycerol delivery, but only energy restriction reduced the assembly. These results show that resveratrol is useful for liver steatosis treatment within a balanced diet, although its effectiveness is lower than that of energy restriction. However, resveratrol is unable to increase the reduction in triacylglycerol content induced by energy restriction.
format Online
Article
Text
id pubmed-5537851
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-55378512017-08-04 Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats Milton-Laskibar, Iñaki Aguirre, Leixuri Fernández-Quintela, Alfredo Rolo, Anabela P. Soeiro Teodoro, João Palmeira, Carlos M. Portillo, María P. Nutrients Article The aims of the present study were to analyze the effect of resveratrol on liver steatosis in obese rats, to compare the effects induced by resveratrol and energy restriction and to research potential additive effects. Rats were initially fed a high-fat high-sucrose diet for six weeks and then allocated in four experimental groups fed a standard diet: a control group, a resveratrol-treated group, an energy restricted group and a group submitted to energy restriction and treated with resveratrol. We measured liver triacylglycerols, transaminases, FAS, MTP, CPT1a, CS, COX, SDH and ATP synthase activities, FATP2/FATP5, DGAT2, PPARα, SIRT1, UCP2 protein expressions, ACC and AMPK phosphorylation and PGC1α deacetylation. Resveratrol reduced triacylglycerols compared with the controls, although this reduction was lower than that induced by energy restriction. The mechanisms of action were different. Both decreased protein expression of fatty acid transporters, thus suggesting reduced fatty acid uptake from blood stream and liver triacylglycerol delivery, but only energy restriction reduced the assembly. These results show that resveratrol is useful for liver steatosis treatment within a balanced diet, although its effectiveness is lower than that of energy restriction. However, resveratrol is unable to increase the reduction in triacylglycerol content induced by energy restriction. MDPI 2017-07-11 /pmc/articles/PMC5537851/ /pubmed/28696376 http://dx.doi.org/10.3390/nu9070737 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Milton-Laskibar, Iñaki
Aguirre, Leixuri
Fernández-Quintela, Alfredo
Rolo, Anabela P.
Soeiro Teodoro, João
Palmeira, Carlos M.
Portillo, María P.
Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats
title Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats
title_full Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats
title_fullStr Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats
title_full_unstemmed Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats
title_short Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats
title_sort lack of additive effects of resveratrol and energy restriction in the treatment of hepatic steatosis in rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537851/
https://www.ncbi.nlm.nih.gov/pubmed/28696376
http://dx.doi.org/10.3390/nu9070737
work_keys_str_mv AT miltonlaskibarinaki lackofadditiveeffectsofresveratrolandenergyrestrictioninthetreatmentofhepaticsteatosisinrats
AT aguirreleixuri lackofadditiveeffectsofresveratrolandenergyrestrictioninthetreatmentofhepaticsteatosisinrats
AT fernandezquintelaalfredo lackofadditiveeffectsofresveratrolandenergyrestrictioninthetreatmentofhepaticsteatosisinrats
AT roloanabelap lackofadditiveeffectsofresveratrolandenergyrestrictioninthetreatmentofhepaticsteatosisinrats
AT soeiroteodorojoao lackofadditiveeffectsofresveratrolandenergyrestrictioninthetreatmentofhepaticsteatosisinrats
AT palmeiracarlosm lackofadditiveeffectsofresveratrolandenergyrestrictioninthetreatmentofhepaticsteatosisinrats
AT portillomariap lackofadditiveeffectsofresveratrolandenergyrestrictioninthetreatmentofhepaticsteatosisinrats